118 results
S-3ASR
EX-5.1
AUTL
Autolus Therapeutics plc
28 Mar 24
Automatic shelf registration
4:10pm
registered office. The word ‘partner,’ used in relation to Cooley (UK) LLP, refers to a member of Cooley (UK) LLP or
an employee or consultant of Cooley … and no partner or employee assumes any personal responsibility for it nor shall owe any duty of care in respect of it.
This letter, the opinions given
S-3ASR
AUTL
Autolus Therapeutics plc
28 Mar 24
Automatic shelf registration
4:10pm
;
persons who acquired ADSs pursuant to the exercise of any employee share option or otherwise as compensation;
persons that own or are deemed … applicable, each filing of an employee benefit plan’s Annual Report pursuant to Section 15(d) of the Securities Exchange Act of 1934
10-K
2023 FY
EX-10.12
AUTL
Autolus Therapeutics plc
21 Mar 24
Annual report
4:55pm
of scientific or technical work carried out by a duly qualified employee of Autolus on or directly related to the work to be conducted under the Agreement … in the relevant jurisdiction. 1.106 “Government Official” means: (a) any officer, employee (including physicians, hospital administrators or other
10-K
2023 FY
AUTL
Autolus Therapeutics plc
21 Mar 24
Annual report
4:55pm
, cloud-based infrastructure, data center facilities, encryption and authentication technology, employee email, content delivery to customers, and other … to the risk of employee fraud or other misconduct or failure to comply with applicable regulatory requirements. Misconduct by employees and independent
10-K
2023 FY
EX-97.1
AUTL
Autolus Therapeutics plc
21 Mar 24
Annual report
4:55pm
and empower any officer or employee of the Company to take any and all actions that the Administrator, in its sole discretion, deems necessary … or appropriate to carry out the purpose and intent of this Policy (other than with respect to any recovery under this Policy involving such officer or employee
8-K
EX-99.1
59f8 a39c4
14 Mar 24
Results of Operations and Financial Condition
12:32pm
424B5
3s82gtkxrcddt5hb081
9 Feb 24
Prospectus supplement for primary offering
5:15pm
8-K
EX-1.1
p2038awpdms66wrgipxt
8 Feb 24
Autolus Announces Pricing of Underwritten Offering
4:17pm
8-K
EX-5.1
c22 08jbk
8 Feb 24
Autolus Announces Pricing of Underwritten Offering
4:17pm
8-K
EX-10.1
0ajwmplrq1304vwga5
8 Feb 24
BioNTech and Autolus Announce Strategic CAR-T Cell Therapy Collaboration to Advance Pipeline and Expand Late-Stage Programs
6:06am
8-K
EX-10.3
g4h 8cj2m3i1dp
8 Feb 24
BioNTech and Autolus Announce Strategic CAR-T Cell Therapy Collaboration to Advance Pipeline and Expand Late-Stage Programs
6:06am
8-K
EX-10.2
u9tiwxh50
8 Feb 24
BioNTech and Autolus Announce Strategic CAR-T Cell Therapy Collaboration to Advance Pipeline and Expand Late-Stage Programs
6:06am
S-3ASR
EX-5.1
7byazaeuoldweugufdiv
7 Feb 24
Automatic shelf registration
10:00pm
S-3ASR
zme d5epsmidqyk
7 Feb 24
Automatic shelf registration
10:00pm
S-3ASR
EX-4.7
20eob
7 Feb 24
Automatic shelf registration
10:00pm
10-Q
mcfg74qg
9 Nov 23
Quarterly report
4:18pm
S-8
x24om igrwjn
3 Nov 23
Registration of securities for employees
4:02pm
S-8
EX-5.1
fp84qwq9 tu
3 Nov 23
Registration of securities for employees
4:02pm
6-K
EX-99.2
924f8
2 Nov 23
Index to Condensed Consolidated Financial Statements
4:26pm
S-8
EX-5.1
vi3ulpi klas97i
7 Aug 23
Registration of securities for employees
4:57pm